This briefing has ended. Read live coronavirus updates here.

stricter guidelines that the agency was preparing for the emergency authorization of coronavirus vaccines.

“Why would we do that?” he asked Margaret Brennan on the CBS program “Face the Nation” on Sunday.

Mr. Meadows said he was interested in the guidelines purely as a matter of quality control: “My challenge to the F.D.A. is just make sure it’s based on science and real numbers.”

The new guidelines under development would lay out more specific criteria for clinical trial data than the current

Continue reading – Article source

Posts from the same category:

    None Found